HK118295A - 1-oxa-2-oxo-3,8-diazaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them - Google Patents

1-oxa-2-oxo-3,8-diazaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them

Info

Publication number
HK118295A
HK118295A HK118295A HK118295A HK118295A HK 118295 A HK118295 A HK 118295A HK 118295 A HK118295 A HK 118295A HK 118295 A HK118295 A HK 118295A HK 118295 A HK118295 A HK 118295A
Authority
HK
Hong Kong
Prior art keywords
formula
compound
oxo
oxa
diazaspiro
Prior art date
Application number
HK118295A
Other languages
German (de)
English (en)
French (fr)
Inventor
Toth Edit
Toerley Jozsef
Sandor Dr Goeroeg
Laszlo Dr Szporny
Kiss Bela
Eva Dr Palosi
Original Assignee
Richter Gedeon Vegyeszeti Gyar R.T.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar R.T. filed Critical Richter Gedeon Vegyeszeti Gyar R.T.
Publication of HK118295A publication Critical patent/HK118295A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
HK118295A 1989-08-10 1995-07-20 1-oxa-2-oxo-3,8-diazaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them HK118295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894094A HU204276B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-4-methylen-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
HK118295A true HK118295A (en) 1995-07-28

Family

ID=10966866

Family Applications (1)

Application Number Title Priority Date Filing Date
HK118295A HK118295A (en) 1989-08-10 1995-07-20 1-oxa-2-oxo-3,8-diazaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them

Country Status (26)

Country Link
US (2) US5132309A (OSRAM)
EP (2) EP0413516B1 (OSRAM)
JP (2) JPH0381277A (OSRAM)
KR (2) KR940002826B1 (OSRAM)
CN (1) CN1025031C (OSRAM)
AT (2) ATE104671T1 (OSRAM)
AU (2) AU621771B2 (OSRAM)
CA (2) CA2023015A1 (OSRAM)
DD (2) DD299428A5 (OSRAM)
DE (2) DE69014008T2 (OSRAM)
DK (1) DK0413516T3 (OSRAM)
ES (2) ES2063923T3 (OSRAM)
FI (1) FI93456C (OSRAM)
HK (1) HK118295A (OSRAM)
HU (2) HU206677B (OSRAM)
IE (1) IE902885A1 (OSRAM)
IL (2) IL95325A (OSRAM)
IN (1) IN170979B (OSRAM)
IS (1) IS3612A7 (OSRAM)
MY (1) MY107240A (OSRAM)
NO (1) NO903511L (OSRAM)
NZ (2) NZ234846A (OSRAM)
PL (2) PL163899B1 (OSRAM)
SG (1) SG59864G (OSRAM)
YU (2) YU150489A (OSRAM)
ZA (3) ZA906299B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074981T3 (es) * 1986-12-17 1995-10-01 Glaxo Group Ltd Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos.
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
GB9206989D0 (en) * 1992-03-31 1992-05-13 Glaxo Group Ltd Chemical compounds
US5756743A (en) 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!
US6100256A (en) * 1996-12-02 2000-08-08 Merck Sharp & Dohme Ltd. Use of NK-1 receptors antagonists for treating schizophrenic disorders
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101770D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
KR20030087248A (ko) * 2002-05-08 2003-11-14 (주)씨엔아이 온라인을 통한 상거래 기초항목의 설정기능을 갖는 상거래관리장치
EP2443124B1 (en) * 2009-06-16 2014-01-22 Merck Sharp & Dohme Corp. Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
GB201416352D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (OSRAM) * 1964-04-22
CH601304A5 (OSRAM) * 1974-02-12 1978-07-14 Buskine Sa
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost

Also Published As

Publication number Publication date
EP0413516B1 (en) 1994-04-20
IL95325A (en) 1994-06-24
IL95325A0 (en) 1991-06-30
JPH0381277A (ja) 1991-04-05
PL164662B1 (pl) 1994-09-30
AU6080490A (en) 1991-02-14
FI903974A0 (fi) 1990-08-10
NZ234843A (en) 1992-03-26
IL95324A0 (en) 1991-06-30
ES2052179T3 (es) 1994-07-01
US5132309A (en) 1992-07-21
SG59864G (en) 1995-09-01
AU6080390A (en) 1991-02-14
HU903233D0 (en) 1990-10-28
DE69008275D1 (de) 1994-05-26
PL291648A1 (en) 1992-06-01
IS3612A7 (is) 1991-02-11
ATE113951T1 (de) 1994-11-15
KR910004631A (ko) 1991-03-29
NO903511L (no) 1991-02-11
ZA906299B (en) 1991-06-26
JPH0383985A (ja) 1991-04-09
IE902885A1 (en) 1991-02-27
KR940000830B1 (ko) 1994-02-02
ATE104671T1 (de) 1994-05-15
CA2023018C (en) 1995-11-28
FI93456B (fi) 1994-12-30
DE69014008D1 (de) 1994-12-15
AU621238B2 (en) 1992-03-05
IL95324A (en) 1994-02-27
PL163899B1 (pl) 1994-05-31
ZA906304B (en) 1991-06-26
KR940002826B1 (ko) 1994-04-04
ZA906300B (en) 1991-05-29
EP0413516A3 (en) 1991-11-27
DE69014008T2 (de) 1995-03-23
MY107240A (en) 1995-10-31
CA2023015A1 (en) 1991-02-11
DK0413516T3 (da) 1994-05-24
HUT59375A (en) 1992-05-28
EP0413516A2 (en) 1991-02-20
DD299431A5 (de) 1992-04-16
NO903511D0 (no) 1990-08-09
US5132303A (en) 1992-07-21
CN1049349A (zh) 1991-02-20
NZ234846A (en) 1992-03-26
IN170979B (OSRAM) 1992-06-27
PL286443A1 (en) 1992-01-13
HU204276B (en) 1991-12-30
EP0412821A3 (en) 1991-11-27
ES2063923T3 (es) 1995-01-16
HU206677B (en) 1992-12-28
DD299428A5 (de) 1992-04-16
HUT55785A (en) 1991-06-28
DE69008275T2 (de) 1994-08-04
EP0412821B1 (en) 1994-11-09
CN1025031C (zh) 1994-06-15
YU150489A (sh) 1992-12-21
AU621771B2 (en) 1992-03-19
CA2023018A1 (en) 1991-02-11
KR910004630A (ko) 1991-03-29
FI93456C (fi) 1995-04-10
YU154090A (sh) 1992-12-21
EP0412821A2 (en) 1991-02-13

Similar Documents

Publication Publication Date Title
EP0412821B1 (en) 1-oxa-2-oxo-3,8-diazaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them
EP0414422B1 (en) 2-Oxo-1-oxa-8-azaspiro [4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
US4434171A (en) Dibenzazepine derivatives, pharmaceutical compositions containing them, and pharmaceutical methods using them
US4853391A (en) Pyrido[1,2-a]indoles and their use as cardiovascular
GB1581500A (en) Pyridobenzodiazepines
US3091568A (en) Therapeutic phthalimidines for relieving cough and producing anesthesia
EP0028381B1 (en) Azepinoindoles, process for their production and pharmaceutical compositions containing them
US5118693A (en) 4,4-disubstituted piperidine derivatives, pharmaceutical compositions containing them and process for preparing same
EP0414421B1 (en) 1-Oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
EP0208447B1 (en) Use of compositions for the manufacture of a medicament for the treatment of psychiatric disorders
US20110003830A1 (en) Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and solvates thereof
US5514700A (en) Substituted 1,2,3,4-tetrahydrocyclopent b!indoles, compositions and use
US4034095A (en) Benzo[5,6]cyclohepta[1,2-c]pyridines
CA2023014A1 (en) 2-oxo-1-oxa-8-azaspiro /4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)